Canaccord Genuity Raising PT and Estimates on ResMed (RMD); Solid Q4
Tweet Send to a FriendGet Alerts RMD Hot Sheet
Price: $47.34 -0.67%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade RMD Now!
Canaccord Genuity maintains a 'Hold' on ResMed (NYSE: RMD) price target of $36.00 (from $32.00).
Analyst, Jason R. Mills, said, "While total revenue narrowly missed our estimate, it matched consensus. Most notably, operating performance was outstanding in FQ4, highlighted by the strongest GM in several quarters, solid OpEx control and announcement of a $0.17 dividend...Revising F2013 sales estimate to $1,506.9M from $1,509.5M but raising our EPS estimate to $2.01 (+13%) from $1.94. We’re also initiating quarterly F2013 EPS estimates of $0.43, $0.48, $0.52, and $0.58 and setting a F2014 EPS estimate of $2.24 (+11% Y/Y)."
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $31.83 yesterday, with a 52 week range of $23.37-$35.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Jason R. Mills, said, "While total revenue narrowly missed our estimate, it matched consensus. Most notably, operating performance was outstanding in FQ4, highlighted by the strongest GM in several quarters, solid OpEx control and announcement of a $0.17 dividend...Revising F2013 sales estimate to $1,506.9M from $1,509.5M but raising our EPS estimate to $2.01 (+13%) from $1.94. We’re also initiating quarterly F2013 EPS estimates of $0.43, $0.48, $0.52, and $0.58 and setting a F2014 EPS estimate of $2.24 (+11% Y/Y)."
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $31.83 yesterday, with a 52 week range of $23.37-$35.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- UPDATE: Raymond James Downgrades Gevo, Inc. (GEVO) to Market Perform
- UPDATE: Canaccord Genuity Starts T-Mobile US, (TMUS) at Hold
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Dividend, Canaccord Genuity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
